These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28559253)

  • 1. Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase.
    Ehteshami M; Zhou L; Amiralaei S; Shelton JR; Cho JH; Zhang H; Li H; Lu X; Ozturk T; Stanton R; Amblard F; McBrayer TR; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
    Feng JY; Xu Y; Barauskas O; Perry JK; Ahmadyar S; Stepan G; Yu H; Babusis D; Park Y; McCutcheon K; Perron M; Schultz BE; Sakowicz R; Ray AS
    Antimicrob Agents Chemother; 2016 Feb; 60(2):806-17. PubMed ID: 26596942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
    Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.
    Fenaux M; Lin X; Yokokawa F; Sweeney Z; Saunders O; Xie L; Lim SP; Uteng M; Uehara K; Warne R; Gang W; Jones C; Yendluri S; Gu H; Mansfield K; Boisclair J; Heimbach T; Catoire A; Bracken K; Weaver M; Moser H; Zhong W
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7077-7085. PubMed ID: 27645237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoramidate prodrugs deliver with potency against hepatitis C virus.
    Mehellou Y
    ChemMedChem; 2010 Nov; 5(11):1841-2. PubMed ID: 20865770
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.
    Arnold JJ; Sharma SD; Feng JY; Ray AS; Smidansky ED; Kireeva ML; Cho A; Perry J; Vela JE; Park Y; Xu Y; Tian Y; Babusis D; Barauskus O; Peterson BR; Gnatt A; Kashlev M; Zhong W; Cameron CE
    PLoS Pathog; 2012; 8(11):e1003030. PubMed ID: 23166498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors.
    Kirschberg TA; Mish MR; Zhang L; Squires NH; Wang KY; Cho A; Feng JY; Fenaux M; Babusis D; Park Y; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1040-3. PubMed ID: 25650256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
    Jin Z; Kinkade A; Behera I; Chaudhuri S; Tucker K; Dyatkina N; Rajwanshi VK; Wang G; Jekle A; Smith DB; Beigelman L; Symons JA; Deval J
    Antiviral Res; 2017 Jul; 143():151-161. PubMed ID: 28412183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
    Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
    Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
    ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase.
    Freedman H; Winter P; Tuszynski J; Tyrrell DL; Houghton M
    J Biol Chem; 2018 Jun; 293(25):9696-9705. PubMed ID: 29739852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of diastereomerically pure nucleotide phosphoramidates.
    Ross BS; Reddy PG; Zhang HR; Rachakonda S; Sofia MJ
    J Org Chem; 2011 Oct; 76(20):8311-9. PubMed ID: 21916475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple
    Lu G; Bluemling GR; Mao S; Hager M; Gurale BP; Collop P; Kuiper D; Sana K; Painter GR; De La Rosa A; Kolykhalov AA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
    Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV RdRp, sofosbuvir and beyond.
    Feng JY; Ray AS
    Enzymes; 2021; 49():63-82. PubMed ID: 34696839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular metabolism and potential cardiotoxicity of a β-D-2'-
    Tao S; Zhou L; Zhang H; Zhou S; Amiralaei S; Shelton J; Ehteshami M; Jiang Y; Amblard F; Coats SJ; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):204-224. PubMed ID: 31595843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus.
    Deval J; Symons JA; Beigelman L
    Curr Opin Virol; 2014 Dec; 9():1-7. PubMed ID: 25194816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
    Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
    J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection.
    Dousson CB
    Antivir Chem Chemother; 2018; 26():2040206618756430. PubMed ID: 29463095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico design of a novel nucleotide antiviral agent by free energy perturbation.
    Patel D; Cox BD; Kasthuri M; Mengshetti S; Bassit L; Verma K; Ollinger-Russell O; Amblard F; Schinazi RF
    Chem Biol Drug Des; 2022 Jun; 99(6):801-815. PubMed ID: 35313085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.